S. Lorenzi, A. D’antuono, M. Iorizzo
Sep 1, 2003
Citations
0
Influential Citations
16
Citations
Journal
Journal of Dermatological Treatment
Abstract
Ganciclovir is a nucleotide‐analogue similar to acyclovir, which has an in vitro activity against herpes simplex type 1, herpes simplex type 2 and varicella zoster virus. Numerous studies suggest that ganciclovir has clinical efficacy against cytomegalovirus disease, as well as an in vivo antiviral effect, and that this agent reduces morbidity of serious cytomegalovirus infections in immunocompromised patients. Generalised cutaneous rash associated with ganciclovir therapy has rarely been reported in literature.